Trial Profile
Warfarin versus Edoxaban for Treatment of Deep Vein Thrombosis (DVT) in Patients with Severe Motor Intellectual Disabilities (SMID)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2018
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms NHOJ-DVT
- 09 Nov 2018 Status changed from recruiting to completed.
- 15 Nov 2016 New trial record